secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001193125-24-163398
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Bio raises $12.6M via equity sales to Armistice & Gilead; cash runway into Q1 2026
--------------------------------------------------------------------------------

- Gross proceeds of $12.6M from sale of common stock and warrants to Armistice Capital and Gilead.
- Armistice bought 634,500 shares + warrants; Gilead bought 179,500 shares + warrants at $15.46/combined unit.
- Warrants exercisable at $17.00/share, expire June 18, 2029; proceeds for general corporate purposes.
- Cash runway extended into Q1 2026; key data readouts: ABI-5366 Phase 1a in Q3 2024, Phase 1b in H1 2025.
- Agreement amendments with Gilead extend timeline for potential ownership increase up to 29.9%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000119312524163398/0001193125-24-163398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000119312524163398/d852840d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-163398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer